Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
T-CAG LifeSciences
Indiatcaglabs.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
T-CAG LifeSciences provides advanced diagnostic services using next-generation sequencing and artificial intelligence to deliver precise genetic analysis. Their offerings include personalized oncology diagnostics, genetic disease predisposition testing, metagenomics research, community health genomic screening programs, and collaborative extramural research. They emphasize innovation in AI-driven genome healthcare research to improve interpretation of genetic data for personalized medicine[2].
- Modalities
- Diagnostic assayNext-generation sequencing (NGS)AI-based analysis
- Industry
- Molecular Diagnostics
Beyond the preview
Go deeper on T-CAG LifeSciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on T-CAG LifeSciences.